Kalimat Medical Center Ltd.

At Kalimat Medical Center Ltd. in Sofia, clinical research in cardiovascular diseases focuses on reducing major events such as heart attack, stroke, and cardiovascular death, while also improving blood pressure control and heart failure care. These studies are designed to test new therapies and combination approaches for people at high risk or living with established heart conditions.

• Prevention of serious cardiovascular events in people at elevated risk
• Improving treatment for hypertension and resistant high blood pressure
• Evaluating new options for heart failure and related complications

The research also examines how therapies may lower the chance of hospitalization and help slow disease progression in patients with complex cardiovascular profiles.

A major part of the site’s work centers on nutritional and metabolic diseases alongside kidney disease, with studies addressing chronic kidney disease, albuminuria, and high proteinuria. The goal is to evaluate treatments that may better protect kidney function and improve metabolic risk factors linked to long-term health outcomes.

• Research in chronic kidney disease with albuminuria or high proteinuria
• Testing therapies to slow kidney function decline
• Studying approaches that may improve metabolic risk in patients with kidney and cardiovascular disease

This area reflects a strong interest in treatments that address both kidney protection and broader cardiometabolic health.

The center is also active in metabolism and lipid disorders, including severe hypertriglyceridemia and elevated lipoprotein(a). These trials aim to test new therapies that can lower harmful blood fats and reduce the risk of future cardiovascular complications.

• Studies in severe hypertriglyceridemia and hypertriglyceridemia
• Investigations targeting lipoprotein(a) and related cardiovascular risk
• Assessing whether new treatments can improve lipid control and prevention

This research is especially relevant for patients whose lipid abnormalities increase their chance of heart disease.

Clinical trials at Kalimat Medical Center Ltd. also include immune system diseases and endocrine-related conditions, particularly Graves’ disease. These studies are focused on finding better ways to restore and maintain normal thyroid function while supporting safer long-term disease management.

• Research on Graves’ disease and thyroid hormone balance
• Evaluating treatments that may help maintain euthyroidism
• Exploring options to improve control of autoimmune thyroid disease

The work in this area aims to improve both symptom control and overall quality of life for patients with autoimmune thyroid disorders.

The site’s nervous system diseases portfolio includes research on insomnia disorder, with a particular interest in sleep treatment for younger patients. These trials are intended to evaluate whether new therapies can improve sleep duration and overall sleep quality in a safe and effective way.

• Studies focused on insomnia disorder in children and adolescents
• Assessing treatments that may improve sleep quality and total sleep time
• Supporting better management of pediatric sleep problems

This area highlights a broader effort to expand treatment options for sleep-related conditions across age groups.